Tuesday, 16 August 2022

FICCI appoints Dr GSK Velu as Chairperson for TN State Council

01 February 2021 | News

With more than 33 years of experience in the healthcare and diagnostics industry, Dr. Velu’s contributions and prominence in the healthcare sector have been recognised and received globally.

Dr GSK Velu has been appointed as the Chairperson of Federation of Indian Chambers of Commerce and Industry (FICCI), Tamil Nadu State Council. Prior to this, he co-chaired the FICCI Tamil Nadu State Council.

Driven by the vision to make medical technology, expertise and quality healthcare available to all, Dr Velu has been promoting high-value health technology and diagnostics offerings through his business initiatives. Currently, he is the Chairman & Managing Director at Neuberg Diagnostics; Chairman & Managing Director at Trivitron Healthcare; Mentor & Shareholder at Kauvery Group of Hospitals; Chairman at Maxivision Eye Hospitals; Founder & Director at Apollo White Dental & Apollo Dialysis; and Anchor Investor at Stakeboat Capital, a private equity fund. He is also the Honorary Consul to The Republic of Estonia in India, wherein the Honorary Consul jurisdiction states include Tamil Nadu, Kerala, Andhra Pradesh and Telangana.

Expressing gratitude and talking about his role, Dr Velu said, "I am thankful for FICCI’s vote of confidence in appointing me as the Chairperson of FICCI Tamil Nadu State Council. This position gives me an opportunity to work within the FICCI framework in meeting its objectives of industry growth at one level, and the nation’s growth at another. I look forward to engaging with industry leaders to foster an ecosystem of innovation and growth, and towards building consensus between the industry and the policymakers.”

With more than 33 years of experience in the healthcare and diagnostics industry, Dr. Velu’s contributions and prominence in the healthcare sector have been recognised and received globally.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account